Institution Directory

Clinical trials at Vanderbilt University Medical Center

Sites in Nashville, TN

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 2:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1269

Shown on this page

Current sort

Live official records

Conditions: Heart Failure, Heart Failure, Diastolic
Interventions: Corvia Atrial Shunt System / IASD System II, Intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE); Device · Other
Lead sponsor: Corvia Medical; Industry
Eligibility: 40 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2031
U.S. locations: 33
States / cities: Phoenix, Arizona • La Jolla, California • Long Beach, California + 28 more

Conditions: Heart Transplant, Heart Failure, Transplant; Failure, Heart
Interventions: Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Assist Transport (XHAT); Device
Lead sponsor: XVIVO Perfusion; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 14
States / cities: La Jolla, California • Los Angeles, California • Stanford, California + 9 more

Conditions: Autism
Interventions: CM-AT; Drug
Lead sponsor: Curemark; Industry
Eligibility: 3 Years to 17 Years
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 31
States / cities: Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 28 more

Conditions: Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis
Interventions: Not listed
Lead sponsor: Target PharmaSolutions, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 15,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 37
States / cities: Lancaster, California • Mission Hills, California • Sacramento, California + 33 more

Conditions: Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Corneal Transplantation
Interventions: Optical coherence tomography (OCT); Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: High-risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (CMML), AML - Acute Myeloid Leukemia, Chronic Myeloid Leukemia
Interventions: CBX-250; Drug
Lead sponsor: Crossbow Therapeutics, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 11
States / cities: Duarte, California • Palo Alto, California • Tampa, Florida + 7 more

Conditions: Autonomic Failure, Pure Autonomic Failure, Parkinson Disease, Multiple System Atrophy, Dementia With Lewy Bodies
Interventions: [18F]FDOPA, Carbidopa 200mg oral dose, Entacapone 400mg oral dose; Drug
Lead sponsor: Daniel Claassen; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Arrhythmia, Atrial Tachycardia, Congenital Heart Disease, Pacemaker Re-Entrant Tachycardia
Interventions: Medtronic; Device
Lead sponsor: Ian Law; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 14
States / cities: Los Angeles, California • Orange, California • Hollywood, Florida + 11 more

Conditions: Achondroplasia
Interventions: BMN 111; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 7 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 6
States / cities: Oakland, California • Torrance, California • Chicago, Illinois + 3 more

Conditions: Multiple System Atrophy, Orthostatic Hypotension, Supine Hypertension
Interventions: Trimethaphan, Placebo; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Scoliosis Idiopathic, Early-Onset Scoliosis Deformity of Spine
Interventions: Casting, Bracing; Procedure · Device
Lead sponsor: University of Iowa; Other
Eligibility: 12 Months to 36 Months
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 24
States / cities: Little Rock, Arkansas • Aurora, Colorado • Wilmington, Delaware + 18 more

About this Vanderbilt University Medical Center institution page

What this page lists: ClinicalTrials.gov records that list Vanderbilt University Medical Center in Nashville, TN as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Vanderbilt University Medical Center

Filter and sort this campus

Live official records

RESPONDER-HF Trial

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

An Open Label Study of CM-AT for the Treatment of Children With Autism

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

Trans-pulmonary Biomarkers in Pulmonary Hypertension

Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

[18F]F-DOPA Imaging in Patients With Autonomic Failure

ATrial Tachycardia PAcing Therapy in Congenital Heart

A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)

Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic

Casting vs Bracing for Idiopathic Early-Onset Scoliosis

About this Vanderbilt University Medical Center institution page